Felis catus gammaherpesvirus 1; a widely endemic potential pathogen of domestic cats

Virology

Volumn 460-461, Issue 1, 2014, Pages 100-107

  Beatty, Julia A ^a   Troyer, Ryan M ^b   Carver, Scott ^c   Barrs, Vanessa R ^a   Espinasse, Fanny ^a   Conradi, Oliver ^a   Stutzman Rodriguez, Kathryn ^b   Chan, Cathy C ^d   Tasker, Séverine ^e   Lappin, Michael R ^b   VandeWoude, Sue ^b  

^a University of Sydney   (Australia)

^b Veterinary Dentistry and Oral Surgery   (United States)

^c UNIVERSITY OF TASMANIA   (Australia)

^d The Animal Doctors Pte Ltd   (Singapore)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Copathogen; Feline; Gammaherpesvirus; Molecular epidemiology; Transmission

Indexed keywords

VIRUS DNA;

ADULT; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUSTRALIA; CAT; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS; FELIS CATUS GAMMAHERPESVIRUS 1; FEMALE; HERPES VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MALE; MIXED INFECTION; MOLECULAR MIMICRY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; SEX DIFFERENCE; SINGAPORE; SMALL INTESTINE; SPECIES ENDEMICITY; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; VIRUS TRANSMISSION; VIRUS VIRULENCE;

COPATHOGEN; FELINE; GAMMAHERPESVIRUS; MOLECULAR EPIDEMIOLOGY; TRANSMISSION;

ANIMALS; ANIMALS, DOMESTIC; AUSTRALIA; CAT DISEASES; CATS; ENDEMIC DISEASES; FEMALE; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; MALE; SINGAPORE; UNITED STATES; VIRAL LOAD;

EID: 84901408184     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.05.007     Document Type: Article

References (46)

1. AVMA, 2012. US Pet Ownership and Demographics Sourcebook. Schaumburg, IL.
2. van Baarle D., Wolthers K.C., Hovenkamp E., Niesters H.G.M., Osterhaus A., Miedema F., van Oers M.H.J. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. J. Infect. Dis. 2002, 186:405-409.
3. Barrs V.R., Beatty J.A., Wilson B.J., Evans N., Gowan R., Baral R.M., Lingard A.E., Perkovic G., Hawley J.R., Lappin M.R. Prevalence of Bartonella species, Rickettsia felis, haemoplasmas and the Ehrlichia group in the blood of cats and fleas in eastern Australia. Aust. Vet. J. 2010, 88:160-165.
4. Batson A. 2008. Global Companion Animal Ownership and Trade: Project Summary, June 2008. WSPA, URL: http://www.wspa.org.uk/Images/Petownershipandtrade-Globalreport_tcm9-10875.pdf.
5. Beatty J.A., Troyer R.M., Brewster C., Rovnak R., Barrs V.R., Quackenbush S.L., VandeWoude S. 2012. Feline immunodeficiency virus (FIV)-associated lymphoma. Is a gammaherpesvirus involved? In: Second International Society for Companion Animal Infectious Diseases Symposium. ISCAID, San Francisco, CA, p. 27 (Abstract 03).
6. Bevins S.N., Carver S., Boydston E.E., Lyren L.M., Alldredge M., Logan K.A., Riley S.P., Fisher R.N., Vickers T.W., Boyce W., Salman M., Lappin M.R., Crooks K.R., VandeWoude S. Three pathogens in sympatric populations of pumas, bobcats, and domestic cats: implications for infectious disease transmission. PLoS One 2012, 7:e31403.
7. Cesarman E Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer Lett. 2011, 305:163-174.
8. Chan C., Beatty J.A., Barrs V.R., Morris A.K., Reagan K., Lappin M.R. Evidence for feline innumodeficiency virus, feline leukaemia virus, Bartonella spp, haemoplasmas and Toxoplasma gondii exposure in Singaporean cats. J. Vet. Intern. Med. 2013, 27:729.
9. Cohen J.I., Fauci A.S., Varmus H., Nabel G.J. Epstein-Barr virus: an important vaccine target for cancer prevention. Sci. Transl. Med. 2011, 3. (107fs107).
10. Dean R.S., Helps C.R., Jones T.J.G., Tasker S. Use of real-time PCR to detect Mycoplasma haemofelis and Candidatus Mycoplasma haemominutum in the saliva and salivary glands of haemoplasma-infected cats. J. Feline Med. Surg. 2008, 10:413-417.
11. Ficova M., Betakova T., Pancik P., Vaclav R., Prokop P., Halasova Z., Kudelova M. Molecular detection of murine herpesvirus 68 in ticks feeding on free-living reptiles. Microb. Ecol. 2011, 62:862-867.
12. Flynn J., Cannon C., Lawrence C., Jarrett O. Polyclonal B-cell activation in cats infected with feline immunodeficiency virus. Immunology 1994, 81:626.
13. Fukayama M., Ushiku T. Epstein-Barr virus-associated gastric carcinoma. Pathol. Res. Pract. 2011, 207:529-537.
14. Gloghini A., Dolcetti R., Carbone A. Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology. Semin. Cancer Biol. 2013, 23:457-467.
15. Goldkamp C.E., Levy J.K., Edinboro C.H., Lachtara J.L. Seroprevalences of feline leukemia virus and feline immunodeficiency virus in cats with abscesses or bite wounds and rate of veterinarian compliance with current guidelines for retrovirus testing. J. Am. Vet. Med. Assoc. 2008, 232:1152-1158.
16. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 1999, 41:95-98.
17. Hardy W.D., Hess P.W., MacEwen E.G., McClelland A.J., Zuckerman E.E., Essex M., Cotter S.M., Jarrett O. Biology of feline leukemia virus in the natural environment. Cancer Res. 1976, 36:582-588.
18. Hellard E., Pontier D., Sauvage F., Poulet H., Fouchet D. True versus false parasite interactions: a robust method to take risk factors into account and Its application to feline viruses. PLoS One 2012, 7:e29618.
19. Hussy D., Janett F., Albini S., Stauber N., Thun R., Ackermann M. Analysis of the pathogenetic basis for shedding and transmission of ovine gamma herpesvirus 2. J. Clin. Microbiol. 2002, 40:4700-4704.
20. Jensen W.A., Fall M.Z., Rooney J., Kordick D.L., Breitschwerdt E.B. Rapid identification and differentiation of Bartonella species using a single-step PCR assay. J. Clin. Microbiol. 2000, 38:1717-1722.
21. Jensen W.A., Lappin M.R., Kamkar S., Reagan W.J. Use of a polymerase chain reaction assay to detect and differentiate two strains of Haemobartonella felis in naturally infected cats. Am. J. Vet. Res. 2001, 62:604-608.
22. Jones K.E., Patel N.G., Levy M.A., Storeygard A., Balk D., Gittleman J.L., Daszak P. Global trends in emerging infectious diseases. Nature 2008, 451:990-993.
23. Kimura H., Ito Y., Suzuki R., Nishiyama Y. Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev. Med. Virol. 2008, 18:305-319.
24. King A.M.Q., Adams M.J., Carstens E.B., Lefkowitz E.J. Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses 2012, Elsevier, London.
25. Knowles S.C.L., Fenton A., Pedersen A.B. Epidemiology and fitness effects of wood mouse herpesvirus in a natural host population. J. Gen. Virol. 2012, 93:2447-2456.
26. Lappin M.R., Greene C.E., Prestwood A.K., Dawe D.L., Tarleton R.L. Enzyme-linked immunosorbent-assay for the detection of circulating antigens of Toxoplasma gondii in the serum of cats. Am. J. Vet. Res. 1989, 50:1586-1590.
27. Lappin M.R., Breitschwerdt E., Brewer M., Hawley J., Hegarty B., Radecki S. Prevalence of Bartonella species antibodies and Bartonella species DNA in the blood of cats with and without fever. J. Feline Med. Surg. 2009, 11:141-148.
28. Levy J.K., Scott H.M., Lachtara J.L., Crawford P.C. Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity. J. Am. Vet. Med. Assoc. 2006, 228:371-376.
29. Liem B.P., Dhand N.K., Pepper A.E., Barrs V.R., Beatty J.A. Clinical findings and survival in cats naturally infected with feline immunodeficiency virus. J. Vet. Intern. Med. 2013, 27:798-805.
30. Macsween K.F., Higgins C.D., McAulay K.A., Williams H., Harrison N., Swerdlow A.J., Crawford D.H. Infectious mononucleosis in university students in the United Kingdom: evaluation of the clinical features and consequences of the disease. Clin. Infect. Dis. 2010, 50:699-706.
31. O'Connor T.P., Tonelli Q.J., Scarlett J.M. Report of the national FELV FIV awareness project. J. Am. Vet. Med. Assoc. 1991, 199:1348-1353.
32. Peterson M.N., Hartis B., Rodriguez S., Green M., Lepczyk C.A. Opinions from the front lines of cat colony management conflict. PLoS One 2012, 5:e44616.
33. Pietersma F., Piriou E., van Baarle D. Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients. Leuk. Lymphoma 2008, 49:1028-1041.
34. Pinches M.D.G., Helps C.R., Gruffydd-Jones T.J., Egan K., Jarrett O., Tasker S. Diagnosis of feline leukaemia virus infection by semi-quantitative real-time polymerase chain reaction. J. Feline Med. Surg. 2007, 9:8-13.
35. Piriou E.R., van Dort K., Nanlohy N.M., Miedema F., van Oers M.H., van Baarle D. Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non-Hodgkin lymphoma. J. Immunol. 2004, 172:6931-6937.
36. Rivailler P., Carville A., Kaur A., Rao P., Quink C., Kutok J.L., Westmoreland S., Klumpp S., Simon M., Aster J.C. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host. Blood 2004, 104:1482-1489.
37. Rowe D.T., Qu L., Reyes J., Jabbour N., Yunis E., Putnam P., Todo S., Green M. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J. Clin. Microbiol. 1997, 35:1612-1615.
38. Shelton G.H., Grant C.K., Cotter S.M., Gardner M.B., Hardy W.D., DiGiacomo R.F. Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968--1988). J. Acquir. Immune Defic. Syndr. 1990, 3:623-630.
39. Stevens S.J.C., Verschuuren E.A.M., Pronk I., van der Bij W., Harmsen M.C., The T.H., Meijer C., AJC van den Brule, Middeldorp J.M. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood 2001, 97:1165-1171.
40. Tasker S. Haemotropic mycoplasmas. What[U+05F3]s their real significance in cats?. J. Feline Med. Surg. 2010, 12:369-381.
41. Thun M.J., DeLancey J.O., Center M.M., Jemal A., Ward E.M. The global burden of cancer: priorities for prevention. Carcinogenesis 2010, 31:100-110.
42. Troyer R.M., Beatty J.A., Stutzman-Rodriguez K.R., Carver S., Lozano C.C., Lee J.S., Lappin M.R., Riley S.P.D., Serieys L.E.K., Logan K.A., Sweanor L.L., Boyce W.M., Vickers T.W., McBride R., Crooks K.R., Lewis J.S., Cunningham M.W., Rovnak J., Quackenbush S.L., VandeWoude S. Novel gammaherpesviruses in North American domestic cats, bobcats and pumas: identification, prevalence and risk factors. J. Virol. 2014, 10.1128/JVI.03405-13.
43. Vahlenkamp T., Tompkins M., Tompkins W. FIV as a model for AIDS pathogenesis studies, p239-273. in vivo Models of HIV Disease and Control 2006, Springer, New York, NY. H. Friedman, S. Specter, M. Bendinelli (Eds.).
44. Yajima M., Imadome K.I., Nakagawa A., Watanabe S., Terashima K., Nakamura H., Ito M., Shimizu N., Honda M., Yamamoto N. A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J. Infect. Dis. 2008, 198:673-682.
45. Yamamoto J., Hansen H., Ho E., Morishita T., Okuda T., Sawa T., Nakamura R., Pedersen N. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J. Am. Vet. Med. Assoc. 1989, 194:213.
46. Zar J.H. Biostatistical Analysis 2010, vol. 5. Prentice Hall Inc., New Jersey. fifth ed.,.